SCHEMBL2804552

SCHEMBL2804552

CC(C)(C)OC(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CTSK P43235 9/20 0.49
ITGB3 P05106 8/20 0.48
ITGA2B P08514 8/20 0.48
CTSS P25774 3/20 0.47
HDAC4 P56524 2/20 0.44
HDAC1 Q13547 2/20 0.44
HDAC6 Q9UBN7 1/20 0.44
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12015102 1.00 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL13385258 0.95 CTSK (0.50) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL7782848 0.94 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL16358853 0.91 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL23608150 0.88 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL376450 0.88 FOLH1 (0.53) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL1304236 0.88 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL918952 0.88 FOLH1 (0.53) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL7150850 0.88 CTSK (0.49) CTSKITGB3ITGA2BCTSSHDAC4
SCHEMBL47004 0.88 FOLH1 (0.53) CTSKITGB3ITGA2BCTSSHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2397488-B1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS FEDERAL STATE BUDGETARY INSTITUTION RES ZAKUSOV INSTITUTE OF PHARMACOLOGY (RU) 2019-03-27 EP disclosed
US-9683014-B2 Dipeptide mimetics of NGF and BDNF neurotrophins UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII IMENI V.V.ZAKUSOVA RAMN (RU) 2017-06-20 US disclosed
EP-1986694-B1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS NOVO NORDISK HEALTHCARE AG (CH) 2015-06-10 EP disclosed
US-20150111828-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII (RU) 2015-04-23 US disclosed
US-20140045753-A1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS NOVO NORDISK HEALTH CARE AG (CH) 2014-02-13 US disclosed
US-20140045753-A1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS NOVO NORDISK HEALTH CARE AG (CH) 2014-02-13 US disclosed
US-20140045753-A1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS NOVO NORDISK HEALTH CARE AG (CH) 2014-02-13 US disclosed
US-20110312895-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS UCHREZHDENIE ROSSIISKOI AKADEMII MEDITSYNSKIKH NAUK NAUCHNO-ISSLEDOVATELSKY INSTITUT FARMAKOLOGII IMENI V.V.ZAKUSOVA RAMN (RU) 2011-12-22 US disclosed
EP-2397488-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS Uchrezhdenie Rossiiskoi Akademii Meditsynskikh Nauk Nauchno-issledovatelsky Institut Farmakologii Imeni V.V.Zakusova Ramn (RU) 2011-12-21 EP disclosed
US-20100221749-A1 THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF UNIVERSITE DE ROUEN 2010-09-02 US disclosed
EP-1850878-A2 C-TERMINALLY PEGYLATED GROWTH HORMONES NOVO NORDISK A/S (DK) 2007-11-07 EP disclosed
WO-2007093594-A1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS NOVO NORDISK HEALTH CARE AG (DK) 2007-08-23 WO disclosed
WO-2006121820-A1 PHOSPHORAMIDATE PRODRUGS FOR TREATMENT OF VIRAL INFECTION VALEANT RESEARCH & DEVELOPMENT (US) 2006-11-16 WO disclosed
WO-2006084888-A2 C-TERMINALLY PEGYLATED GROWTH HORMONES NOVO NORDISK A/S (DK) 2006-08-17 WO disclosed
US-5776901-A Polypeptide analogues having growth hormone releasing activity ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1998-07-07 US disclosed
EP-0605484-A1 PEPTIDES HAVING GROWTH HORMONE RELEASING ACTIVITY THE ADMINISTRATORS OF THE TULANE UNIVERSITY EDUCATIONAL FUND (US) 1994-07-13 EP disclosed
WO-1993004081-A1 PEPTIDES HAVING GROWTH HORMONE RELEASING ACTIVITY ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) 1993-03-04 WO disclosed
WO-1992001711-A1 POLYPEPTIDE COMPOUNDS HAVING GROWTH HORMONE RELEASING ACTIVITY POLYGEN HOLDING CORPORATION (US) 1992-02-06 WO disclosed
WO-1992001709-A1 PROCESS FOR SYNTHESIZING PEPTIDES EASTMAN KODAK COMPANY (US) 1992-02-06 WO disclosed
EP-0228192-A2 Renin-inhibitory oligopeptides, their preparation and use SANKYO COMPANY LIMITED (JP) 1987-07-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150111828-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS BDNF, NTRK2, NGF CTSK 2077/4885ITGB3 2685/4885ITGA2B 3194/4885
US-20140045753-A1 COUPLING OF POLYPEPTIDES AT THE C-TERMINUS PTMS, VIP, LNPEP CTSK 746/4885ITGB3 1524/4885ITGA2B 2287/4885
US-20100221749-A1 THREE-FUNCTIONAL PSEUDO-PEPTIDIC REAGENT, AND USES AND APPLICATIONS THEREOF DNPEP, PEPD, LNPEP CTSK 357/4885ITGB3 979/4885ITGA2B 3144/4885
US-20110312895-A1 DIPEPTIDE MIMETICS OF NGF AND BDNF NEUROTROPHINS BDNF, NTRK2, NGF CTSK 2077/4885ITGB3 2685/4885ITGA2B 3194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.